KATHRINA PANER: Open Payments
NPI 1114152345 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 39 payments from 7 companies in 2025. Trend: 2023 $546 · 2024 $937 · 2025 $1,008
Food & beverage: $938Education: $71
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $300 |
| GENZYME CORPORATION | 14 | $266 |
| GlaxoSmithKline, LLC. | 9 | $193 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| SANOFI-AVENTIS U.S. LLC | 1 | $53 |
| Amgen Inc. | 2 | $47 |
| Optinose US, Inc. | 1 | $25 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, Xhance.
Industry payments across NV — which companies pay providers there.
